Form 8-K Arcus Biosciences, Inc. For: Oct 20

Go back to Form 8-K Arcus Biosciences, Inc. For: Oct 20

Citi reiterates buy rating on Arcus Biosciences after stock drops 20%

October 21, 2026 4:54 PM EDT

Citi analyst Yigal Nochomovitz reiterated a Buy rating and $50.00 price target on Arcus Biosciences (NYSE: RCUS) following a 20% drop in the company's share price.

According to the analyst, the stock's decline was driven in part by a follow-on offering and market expectations that the company's... More